BIOMAT Database Logo BIOMAT Database Logo

Purification and crystallization of human anaphylatoxin, C3a. 1980

E P Pâques, and H Scholze, and R Huber

UI MeSH Term Description Entries
D010443 Peptide Chain Termination, Translational A process of GENETIC TRANSLATION whereby the terminal amino acid is added to a lengthening polypeptide. This termination process is signaled from the MESSENGER RNA, by one of three termination codons (CODON, TERMINATOR) that immediately follows the last amino acid-specifying CODON. Chain Termination, Peptide, Translational,Protein Biosynthesis Termination,Protein Chain Termination, Translational,Protein Translation Termination,Translation Termination, Genetic,Translation Termination, Protein,Translational Peptide Chain Termination,Translational Termination, Protein,Biosynthesis Termination, Protein,Genetic Translation Termination,Protein Translational Termination,Termination, Genetic Translation,Termination, Protein Biosynthesis,Termination, Protein Translation,Termination, Protein Translational
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000706 Anaphylatoxins Serum peptides derived from certain cleaved COMPLEMENT PROTEINS during COMPLEMENT ACTIVATION. They induce smooth MUSCLE CONTRACTION; mast cell HISTAMINE RELEASE; PLATELET AGGREGATION; and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from the strongest to the weakest is C5a, C3a, C4a, and C5a des-arginine. Anaphylatoxin

Related Publications

E P Pâques, and H Scholze, and R Huber
Purification and partial characterization of human and porcine C3a anaphylatoxin.
February 1975, The Journal of biological chemistry,
E P Pâques, and H Scholze, and R Huber
Purification, characterization, and amino acid sequence of rat anaphylatoxin (C3a).
November 1978, Biochemistry,
E P Pâques, and H Scholze, and R Huber
Anaphylatoxin C3a peptide contracts human pulmonary vasculature.
January 1988, Pulmonary pharmacology,
E P Pâques, and H Scholze, and R Huber
Cardiac dysfunction caused by purified human C3a anaphylatoxin.
February 1985, Proceedings of the National Academy of Sciences of the United States of America,
E P Pâques, and H Scholze, and R Huber
Structure and function of C3a anaphylatoxin.
January 1990, Current topics in microbiology and immunology,
E P Pâques, and H Scholze, and R Huber
Molecular cloning and characterization of the human anaphylatoxin C3a receptor.
August 1996, The Journal of biological chemistry,
E P Pâques, and H Scholze, and R Huber
Anaphylatoxin C3a receptors in asthma.
February 2005, Respiratory research,
E P Pâques, and H Scholze, and R Huber
The active site of C3a anaphylatoxin.
November 1980, The Journal of biological chemistry,
E P Pâques, and H Scholze, and R Huber
Designing synthetic superagonists of C3a anaphylatoxin.
April 1991, Biochemistry,
E P Pâques, and H Scholze, and R Huber
Active recombinant C3a of human anaphylatoxin produced in Escherichia coli.
March 1991, Biochemical and biophysical research communications,
Copied contents to your clipboard!